• Publications
  • Influence
Recommendations for Conduct, Methodological Practices, and Reporting of Cost-effectiveness Analyses: Second Panel on Cost-Effectiveness in Health and Medicine.
IMPORTANCE Since publication of the report by the Panel on Cost-Effectiveness in Health and Medicine in 1996, researchers have advanced the methods of cost-effectiveness analysis, and policy makersExpand
  • 813
  • 64
  • Open Access
Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold.
The ratio of $50,000 per quality-adjusted life-year (QALY) gained by using a given health care intervention has long served as a benchmark for the value of U.S. health care. But evidence suggestsExpand
  • 1,059
  • 53
  • Open Access
Long-term Persistence in Use of Statin Therapy in Elderly Patients
ContextKnowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy is limited because previous studies have observed patients for short periodsExpand
  • 803
  • 21
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.
OBJECTIVE Attention-deficit/hyperactivity disorder (ADHD) is one of the most prevalent mental disorders in children in the United States and often persists into adulthood with associatedExpand
  • 243
  • 20
  • Open Access
Using real-world data for coverage and payment decisions: the ISPOR Real-World Data Task Force report.
OBJECTIVES Health decision-makers involved with coverage and payment policies are increasingly developing policies that seek information on "real-world" (RW) outcomes. Motivated by these initiatives,Expand
  • 423
  • 18
  • Open Access
Examining the value and quality of health economic analyses: implications of utilizing the QHES.
OBJECTIVE To examine the increasing use of health economic studies and practical implications of evaluating their quality utilizing the Quality of Health Economic Studies (QHES) instrument. METHODSExpand
  • 221
  • 17
  • Open Access
Long-term persistence in use of statin therapy in elderly patients.
CONTEXT Knowledge of long-term persistence with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor (statin) therapy is limited because previous studies have observed patients for short periodsExpand
  • 372
  • 14
  • Open Access
Key principles for the improved conduct of health technology assessments for resource allocation decisions.
Health technology assessment (HTA) is a dynamic, rapidly evolving process, embracing different types of assessments that inform real-world decisions about the value (i.e., benefits, risks, and costs)Expand
  • 344
  • 13
  • Open Access
Does preventive care save money? Health economics and the presidential candidates.
A popular component of the candidates' plans for controlling spiraling health care costs involves greater promotion of preventive health measures. Joshua Cohen, Peter Neumann, and Milton WeinsteinExpand
  • 399
  • 13
Development and Validation of a Grading System for the Quality of Cost-Effectiveness Studies
Purpose.To provide a practical quantitative tool for appraising the quality of cost-effectiveness (CE) studies. Methods.A committee comprised of health economists selected a set of criteria for theExpand
  • 227
  • 12